Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. FBIOX: which is better?

Bottom line

BBH vs FBIOX: the short answer

BBH (VanEck Biotech ETF) and FBIOX (Biotechnology Portfolio) are quite different portfolios: only about 36% of their top holdings (by weight) are shared.

But FBIOX is far broader, holding 215 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

BBH is cheaper at 0.35% vs 0.62% — a difference of $27 a year per $10,000 invested.

Over five years, FBIOX returned +3.5% a year vs +2.7% for BBH (reporting dates differ).

Updated Nov 19, 2026

BBH vs FBIOX side by side

BBHFBIOX
TypeETFMutual fund
Fund familyVanEckFidelity
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.62%
Annual cost per $10k$35$62
10-yr cost on $10k (prospectus)$443$774
Max front loadNone—
12b-1 fee—0%
1-yr return+21.2%+36.4%
5-yr return (annualized)+2.7%+3.5%
10-yr return (annualized)+4.5%+6.9%
Best quarter+27.6%+33.6%
Worst quarter−18.2%−28.4%
Net assets (fund)$395.6M$5.3B
Number of holdings25215
Portfolio turnover19%45%
Returns as ofDec 31, 2025Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHFBIOXDifference
2025+21.2%+36.4%−15.2%
2024−4.4%+7.3%−11.7%
2023+3.9%+10.1%−6.2%
2022−15.1%−15.9%+0.8%
2021+11.8%−12.4%+24.1%
2020+22.1%+38.3%−16.3%
2019+25.8%+36.0%−10.2%
2018−10.2%−10.7%+0.5%
2017+16.6%+27.9%−11.2%
2016−15.0%−23.7%+8.7%

Source: Fund prospectus bar charts

Holdings overlap

9 of BBH's top 25 holdings also appear in FBIOX's top 25.

Shared top holdings
HoldingBBHFBIOX
Amgen Inc15.25%6.53%
Gilead Sciences Inc12.79%4.82%
Revolution Medicines Inc5.27%2.02%
Argenx SE4.97%2.25%
Natera Inc4.92%1.41%
Alnylam Pharmaceuticals Inc3.83%2.93%
Biogen Inc3.63%1.26%
Moderna Inc3.36%1.28%
Insmed Inc2.67%2.25%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

FAQ

What is the difference between BBH and FBIOX?
BBH (VanEck Biotech ETF) and FBIOX (Biotechnology Portfolio) are quite different portfolios: only about 36% of their top holdings (by weight) are shared. But FBIOX is far broader, holding 215 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or FBIOX?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and FBIOX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.